评估转换生物制剂在治疗严重喘患者中的安全性和有效性
Leena Al Awn1,2,3, Maha AlAmmari1,2,3, Dalal AlAbdulkarim1,2,3
1Department of Pharmaceutical Care Services, King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
切换生物药物治疗严重喘是安全和有效的,当初始治疗是次优的. 这种做法可以减少恶化并改善难以控制的喘患者的鼻症状.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
背景情况:
- 严重的喘管理可能具有挑战性,沙特喘倡议 (SINA) 将其定义为在SINA第4阶段不受控制的喘.
- 对于严重喘患者来说,选择最佳的生物药物需要仔细考虑.
- 切换生物药物是对初始治疗反应不足的患者的常见策略.
研究的目的:
- 评估在患有严重喘的患者中切换生物药物的安全性和有效性.
- 评估在接受不同生物药物的严重喘患者的结果.
主要方法:
- 一项观察性回顾性队列研究在第三级护理中心进行.
- 包括患有严重喘的成年患者 (≥18岁),在生物药物 (奥马利祖马布,梅波利祖马布,杜皮卢马布) 之间切换.
- 分析了转换原因,治疗持续时间和临床结果的数据.
主要成果:
- 分析了33名患者,81%的患者因缺乏疗效而转换.
- 在转换生物药物后,恶化病例的平均数量从6.6下降到3.9 (p=0.1).
- 鼻症状有所改善,报告的改善率从18.5%增加到37.5% (p=0.1).
结论:
- 切换生物药物是严重喘患者的安全和有效策略,初始治疗无法实现最佳控制.
- 当前的国家和国际指导方针应包括在严重喘中切换生物疗法的具体标准.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
